Is AstraZeneca (AZN) Preserving Cash for a Forest Labs (FRX) Bid?
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
AstraZeneca (AZN) Suspends Buybacks; Aims to Maintain Financial Flexibility
October 1, 2012 9:08 AM EDTAstraZeneca (NYSE: AZN) announced that it is suspending share repurchases with
immediate effect. During 2012 the company has completed net share repurchases
of $2.3 billion in respect of its initial target of $4.5 billion.
AstraZeneca confirms its Core EPS target range for the Full Year 2012... More
